Gliomas are the most common primary malignant brain tumor, representing more than half of the 18,000 malignant brain tumors diagnosed annually in the U.
What does PMBT stand for?
PMBT stands for Primary Malignant Brain Tumor (neurology and oncology)
This definition appears rarely and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of PMBT
We have 1 other meaning of PMBT in our Acronym Attic
- Preliminary Multistate Bar Review (exam preparatory course)
- Primary Master Boot Record
- Professional Multistate Bar Review (bar examination preparation)
- Pharmaceutical and Molecular Biotechnology Research Centre (Ireland)
- Packet Mode Bearer Service
- Pintle Motion Base Simulator
- Police Main Base Station (UK)
- Portable Medical Benefits Scheme (Singapore)
- Post-Movement Beta Synchronization
- Prasetiya Mulya Business School (Indonesia)
- Propellant Mean Bulk Temperature
- Pathogen Molecular Biology Unit (University of London School of Hygiene & Tropical Medicine)
- Percutaneous Mitral Balloon Valvuloplasty
- Private Manual Branch Exchange
- Caracas Metropolitan Police
- Chief Patternmaker (Naval Rating)
- Pacific Marine Center
- Pacific Municipal Consultants (California)
- Packet Mode Channel
- Pain Management Center
Samples in periodicals archive:
More than 18,000 primary malignant brain tumors are diagnosed each year in the United States; about 9,000 of those are malignant gliomas, according to the National Cancer Institute.
This means that approximately 11,170 males and 9,330 females in the United States were diagnosed with a primary malignant brain tumor in 2007 (Jemal et al.
Thirty percent of brain tumor patients survive five years following the diagnosis of a primary malignant brain tumor.
Polifeprosan (Gliadel) was approved several years ago as a localized treatment for recurrent primary malignant brain tumor.
4 million individuals with cancer in 2008, 30 to 40 percent will develop brain metastasis compared to the approximately 17,000 new cases annually of primary malignant brain tumors, cancers that originate in the brain.
More than 35,000 Americans have GBM, which accounts for approximately 52% of all primary malignant brain tumors, and approximately 13,000 will die each year from the disease.
The most difficult challenge in the treatment of primary malignant brain tumors may be delivering targeted therapies that conserve healthy brain tissue while effectively eradicating cancer.